Molecular Studies of Canakinumab in High-Risk Former-Smokers (CANIFS)
Latest Information Update: 01 Aug 2024
At a glance
- Drugs Canakinumab (Primary)
- Indications Respiratory tract neoplasms
- Focus Therapeutic Use
- Acronyms CANIFS
Most Recent Events
- 30 Jul 2024 Status changed from not yet recruiting to recruiting.
- 20 Sep 2023 New trial record